InvestSMART
  1. Home
  2. Research & Advice
  3. Research Tools
  4. Shares
  5. Betashares Global Healthcare ETF - Currency Hedged (DRUG)
  6. Company Announcements

Betashares Global Healthcare ETF - Currency Hedged (ASX: DRUG) - Announcements

Current share price for DRUG : $7.980 0.04 (0.50%)+

Betashares Global Healthcare ETF - Currency Hedged (DRUG) is an Exchange Traded Fund - commonly known as an ETF. For more details about how ETFs work, feel free to check out our What is an ETF? overview. Betashares Global Healthcare ETF -Currency Hedged (DRUG) provides simple, cost-effective and transparent exposure to the largest companies in the global healthcare sector. The Fund aims to track the performance of an index (before fees and expenses) which provides exposure to the performance of the largest global healthcare companies by market capitalization (excluding companies in Australia), hedged into Australian dollars.

Latest company announcements for Betashares Global Healthcare ETF - Currency Hedged (DRUG)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$183 Distribution Timetable 23 Dec 2020 5:23PM $6.860 $7.980 risen by 16.33%
$183 Units on Issue Disclosure - Nov 2020 4 Dec 2020 3:55PM $6.880 $7.980 risen by 15.99%
$183 Units on Issue Disclosure - Oct 2020 5 Nov 2020 11:15AM $6.740 $7.980 risen by 18.40%
$183 Units on Issue Disclosure - Sep 2020 6 Oct 2020 1:42PM $6.700 $7.980 risen by 19.10%
$183 Annual Financial Report 28 Sep 2020 2:17PM $6.620 $7.980 risen by 20.54%
$183 Units on Issue Disclosure - Aug 2020 4 Sep 2020 10:36AM $6.680 $7.980 risen by 19.46%
$183 Units on Issue Disclosure - July 2020 6 Aug 2020 1:23PM $6.670 $7.980 risen by 19.64%
$183 Estimated Annual Distribution Component Information 7 Jul 2020 12:47PM $6.630 $7.980 risen by 20.36%
$183 Units on Issue Disclosure - June 2020 6 Jul 2020 3:07PM $6.670 $7.980 risen by 19.64%
$183 DRP Issue Price 1 Jul 2020 6:01PM $6.520 $7.980 risen by 22.39%
$183 Final Distribution Announcement 30 Jun 2020 7:05PM $6.480 $7.980 risen by 23.15%
$183 Estimated Distribution Announcement 29 Jun 2020 7:14PM $6.460 $7.980 risen by 23.53%
$183 Distribution Timetable 24 Jun 2020 11:04AM $6.620 $7.980 risen by 20.54%
$183 Units on Issue Disclosure - May 2020 4 Jun 2020 11:33AM $6.630 $7.980 risen by 20.36%
$183 Units on Issue Disclosure - Apr 2020 6 May 2020 2:48PM $6.580 $7.980 risen by 21.28%
$183 Units on Issue Disclosure - Mar 2020 7 Apr 2020 2:51PM $6.060 $7.980 risen by 31.68%
$183 Units on Issue Disclosure - Feb 2020 5 Mar 2020 3:21PM $6.420 $7.980 risen by 24.30%
$183 Units on Issue Disclosure - Jan 2020 6 Feb 2020 3:02PM $6.820 $7.980 risen by 17.01%
$183 Indicative 2020 Distributions Calendar 31 Jan 2020 4:31PM $6.620 $7.980 risen by 20.54%
$183 Estimated Distribution Component Information 8 Jan 2020 4:59PM $6.590 $7.980 risen by 21.09%
$183 Units on Issue Disclosure - Dec 2019 7 Jan 2020 5:42PM $6.630 $7.980 risen by 20.36%
$183 DRP Issue Price 2 Jan 2020 5:59PM $6.660 $7.980 risen by 19.82%
$183 Final Distribution Announcement 2 Jan 2020 8:13AM $6.660 $7.980 risen by 19.82%
$183 Estimated Distribution Announcement 30 Dec 2019 6:09PM $6.690 $7.980 risen by 19.28%
$183 Distribution Timetable 23 Dec 2019 5:39PM $6.610 $7.980 risen by 20.73%

101 - 125 of 129 results

Page 5 of 6

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.